{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:23Z","timestamp":1793141843320,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamaophthalmol.2018.2986","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T18:41:14Z","timestamp":1533235274000},"page":"1115","source":"Crossref","is-referenced-by-count":36,"title":["Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation"],"prefix":"10.1001","volume":"136","author":[{"given":"Eszter","family":"Szalai","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Department of Ophthalmology, University of Debrecen, Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, Georgia State University, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"van Poppelen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine J.","family":"Jager","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Centre, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"de Klein","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Kilic","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans E.","family":"Grossniklaus","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Department of Pathology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"eoi180059r1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bjo.62.6.420","article-title":"Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells.","volume":"62","author":"Zimmerman","year":"1978","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"eoi180059r2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"eoi180059r3","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/bjo.2003.029058","article-title":"The Zimmerman-McLean-Foster hypothesis: 25 years later.","volume":"88","author":"Singh","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"eoi180059r4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaophthalmol.2013.2547","article-title":"Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture.","volume":"131","author":"Grossniklaus","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"eoi180059r5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases.","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi180059r6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"eoi180059r7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"eoi180059r8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jtbi.2005.10.021","article-title":"Stochastic dynamics of metastasis formation.","volume":"240","author":"Michor","year":"2006","journal-title":"J Theor Biol"},{"issue":"7","key":"eoi180059r9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jamaophthalmol.2016.0913","article-title":"Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma.","volume":"134","author":"Walter","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"eoi180059r10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ophtha.2017.07.018","article-title":"Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis","volume":"125","author":"Szalai","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi180059r11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00417-017-3856-x","article-title":"Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.","volume":"256","author":"Nguyen","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"eoi180059r12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ajo.2016.03.046","article-title":"Tumor volumes in choroidal melanoma: agreement between three-dimensional ultrasound and two mathematical models.","volume":"166","author":"Caminal","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"eoi180059r13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.ophtha.2006.08.056","article-title":"Estimating choroidal melanoma volume: comparison of methods.","volume":"114","author":"Singh","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi180059r14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/genetics\/148.4.1483","article-title":"The mutation rate and cancer.","volume":"148","author":"Jackson","year":"1998","journal-title":"Genetics"},{"issue":"3","key":"eoi180059r15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ng.3489","article-title":"Identification of neutral tumor evolution across cancer types.","volume":"48","author":"Williams","year":"2016","journal-title":"Nat Genet"},{"issue":"7","key":"eoi180059r16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/archopht.1985.01050070050028","article-title":"Comparison of uveal melanoma growth rates with mitotic index and mortality.","volume":"103","author":"Gass","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"eoi180059r17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0161-6420(00)00607-2","article-title":"Uveal melanoma: implications of tumor doubling time.","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi180059r18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S0161-6420(84)34088-X","article-title":"Growth rates and doubling times of posterior uveal melanomas.","volume":"91","author":"Augsburger","year":"1984","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi180059r19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/archopht.1997.01100160184007","article-title":"Uveal melanoma: growth rate and prognosis.","volume":"115","author":"Char","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"eoi180059r20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00000372-200308000-00003","article-title":"Tumor doubling time of cutaneous melanoma and its metastasis.","volume":"25","author":"Carlson","year":"2003","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"eoi180059r21","first-page":"199","article-title":"Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study.","volume":"24","author":"Arai","year":"1994","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"eoi180059r22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/02841868909111193","article-title":"Tumor cell proliferation kinetics and tumor growth rate.","volume":"28","author":"Tubiana","year":"1989","journal-title":"Acta Oncol"},{"issue":"8","key":"eoi180059r23","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"issue":"25","key":"eoi180059r24","doi-asserted-by":"publisher","first-page":"14800","DOI":"10.1073\/pnas.93.25.14800","article-title":"The mutation rate and cancer.","volume":"93","author":"Tomlinson","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"eoi180059r25","first-page":"407","article-title":"Mutation rate of normal and malignant human lymphocytes.","volume":"47","author":"Seshadri","year":"1987","journal-title":"Cancer Res"},{"issue":"4","key":"eoi180059r26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/21548331.1983.11702514","article-title":"Biology and tumor growth.","volume":"18","author":"Tannock","year":"1983","journal-title":"Hosp Pract (Off Ed)"},{"issue":"1","key":"eoi180059r27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma.","volume":"9","author":"Field","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"eoi180059r28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","article-title":"Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.","volume":"153","author":"Luzzi","year":"1998","journal-title":"Am J Pathol"},{"issue":"1","key":"eoi180059r29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.09-4138","article-title":"Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis.","volume":"51","author":"Yang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi180059r30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1167\/iovs.16-20212","article-title":"The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status.","volume":"58","author":"Dogrus\u00f6z","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"24","key":"eoi180059r31","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification.","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"eoi180059r32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ophtha.2010.05.023","article-title":"Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens.","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi180059r33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma.","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"issue":"7","key":"eoi180059r34","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes.","volume":"134","author":"Decatur","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi180059r35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/bjc.2017.259","article-title":"GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi.","volume":"117","author":"Vader","year":"2017","journal-title":"Br J Cancer"},{"issue":"9","key":"eoi180059r36","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1167\/iovs.11-9280","article-title":"Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.","volume":"53","author":"Bronkhorst","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi180059r37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1167\/iovs.10-5979","article-title":"Detection of M2-macrophages in uveal melanoma and relation with survival.","volume":"52","author":"Bronkhorst","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi180059r38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1167\/iovs.07-0786","article-title":"Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.","volume":"49","author":"Maat","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6009","key":"eoi180059r39","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas.","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"10","key":"eoi180059r40","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/modpathol.2014.43","article-title":"Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.","volume":"27","author":"Koopmans","year":"2014","journal-title":"Mod Pathol"},{"issue":"5","key":"eoi180059r41","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma.","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"37","key":"eoi180059r42","doi-asserted-by":"publisher","first-page":"59209","DOI":"10.18632\/oncotarget.v7i37","article-title":"Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.","volume":"7","author":"Field","year":"2016","journal-title":"Oncotarget"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jamaophthalmology\/fullarticle\/2694811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T17:47:47Z","timestamp":1661708867000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.2986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.2986","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}